UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review

Pharmacology & therapeutics (Oxford), 2014, Vol.141 (1), p.92-116

2014

Volltextzugriff (PDF)

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

Clinical pharmacology and therapeutics, 2009-09, Vol.86 (3), p.299-306

2009

Volltextzugriff (PDF)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Translational psychiatry, 2015-04, Vol.5 (4), p.e553-e553

2015

Volltextzugriff (PDF)

Pharmacogenomic aspects of bipolar disorder: An update

European neuropsychopharmacology, 2017-06, Vol.27 (6), p.599-609

2017

Volltextzugriff (PDF)

Personalisierte Pharmakotherapie: Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2013, Vol.56 (11), p.1509-1521

2013

Volltextzugriff (PDF)

Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2

Clinical pharmacology and therapeutics, 2016-12, Vol.100 (6), p.606-616

2016

Volltextzugriff (PDF)

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

Molecular psychiatry, 2013-03, Vol.18 (3), p.273-287

2013

Volltextzugriff (PDF)

OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics

Clinical pharmacology and therapeutics, 2016-06, Vol.99 (6), p.633-641

2016

Volltextzugriff (PDF)

Interindividual Variation in the Pharmacokinetics of Δ9‐Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9

Clinical pharmacology and therapeutics, 2009-03, Vol.85 (3), p.273-276

2009

Volltextzugriff (PDF)

Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers

Clinical pharmacology and therapeutics, 2009-07, Vol.86 (1), p.54-61

2009

Volltextzugriff (PDF)

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Molecular psychiatry, 2004-05, Vol.9 (5), p.442-473

2004

Volltextzugriff (PDF)

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication

The pharmacogenomics journal, 2007-08, Vol.7 (4), p.257-265

2007

Volltextzugriff (PDF)

Why, When, and How Should Pharmacogenetics Be Applied in Clinical Studies?: Current and Future Approaches to Study Designs

Clinical pharmacology and therapeutics, 2011-02, Vol.89 (2), p.198-209

2011

Volltextzugriff (PDF)

Pharmacokinetics of Mirtazapine: Enantioselective Effects of the CYP2D6 Ultra Rapid Metabolizer Genotype and Correlation with Adverse Effects

Clinical pharmacology and therapeutics, 2007-05, Vol.81 (5), p.699-707

2007

Volltextzugriff (PDF)

Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol

Clinical pharmacology and therapeutics, 2011-07, Vol.90 (1), p.143-150

2011

Volltextzugriff (PDF)

Individual variability in the Phamacokinetic of Tea Polyphenols and gene expression after oral intake of Green Tea extrakt

Clinical therapeutics, 2015-08, Vol.37 (8), p.e116-e116

2015

Volltextzugriff (PDF)

The Polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 Allele 3 Independently Affect Torsemide Pharmacokinetics and Pharmacodynamics

Clinical pharmacology and therapeutics, 2008-06, Vol.83 (6), p.815-817

2008

Volltextzugriff (PDF)

Functional Polymorphisms of the Human Multidrug-Resistance Gene: Multiple Sequence Variations and Correlation of One Allele with P-Glycoprotein Expression and Activity in vivo

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3473-3478

2000

Volltextzugriff (PDF)

OC001—A Promising Predictor For Heart Diseases And Diuretic Drug Therapy In The Aldosterone Receptor Gene

Clinical therapeutics, 2013-08, Vol.35 (8), p.e1-e1

2013

Volltextzugriff (PDF)

P265 Influence of caffeine on cortical plasticity generated by 140 Hz tACS and 25 ms PAS: A randomized controlled double-blinded trial

Clinical neurophysiology, 2020-04, Vol.131 (4), p.e164-e165

2020

Volltextzugriff (PDF)

Population Pharmacokinetics of Melphalan and Glutathione S‐transferase Polymorphisms in Relation to Side Effects

Clinical pharmacology and therapeutics, 2008-05, Vol.83 (5), p.749-757

2008

Volltextzugriff (PDF)

Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron

The pharmacogenomics journal, 2012-02, Vol.12 (1), p.22-29

2012

Volltextzugriff (PDF)

Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity

The pharmacogenomics journal, 2008-08, Vol.8 (4), p.297-304

2008

Volltextzugriff (PDF)

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants:a first step towards subpopulation-specific dosages

Acta psychiatrica Scandinavica, 2001-09, Vol.104 (3), p.173-192

2001

Volltextzugriff (PDF)

Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines

Clinical neurophysiology, 2017-09, Vol.128 (9), p.1774-1809

2017

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Englisch
(277)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(198)
Science & Technology
(179)
Life Sciences & Biomedicine
(177)
Biological And Medical Sciences
(132)
Medical Sciences
(115)
Male
(106)
Pharmacology & Pharmacy
(102)
Adult
(90)
Female
(86)
Pharmacology. Drug Treatments
(83)
Genotype
(82)
Middle Aged
(76)
Polymorphism, Genetic
(52)
Aged
(47)
Alleles
(47)
Pharmacogenetics
(40)
Phenotype
(37)
General Pharmacology
(34)
Genetics & Heredity
(34)
Cytochrome P-450 Enzyme System - Genetics
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Pharmacogenomic aspects of bipolar disorder: An update

Personalisierte Pharmakotherapie: Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik

Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics

Interindividual Variation in the Pharmacokinetics of Δ9‐Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9

Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication

Why, When, and How Should Pharmacogenetics Be Applied in Clinical Studies?: Current and Future Approaches to Study Designs

Pharmacokinetics of Mirtazapine: Enantioselective Effects of the CYP2D6 Ultra Rapid Metabolizer Genotype and Correlation with Adverse Effects

Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol

Individual variability in the Phamacokinetic of Tea Polyphenols and gene expression after oral intake of Green Tea extrakt

The Polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 Allele 3 Independently Affect Torsemide Pharmacokinetics and Pharmacodynamics

Functional Polymorphisms of the Human Multidrug-Resistance Gene: Multiple Sequence Variations and Correlation of One Allele with P-Glycoprotein Expression and Activity in vivo

OC001—A Promising Predictor For Heart Diseases And Diuretic Drug Therapy In The Aldosterone Receptor Gene

P265 Influence of caffeine on cortical plasticity generated by 140 Hz tACS and 25 ms PAS: A randomized controlled double-blinded trial

Population Pharmacokinetics of Melphalan and Glutathione S‐transferase Polymorphisms in Relation to Side Effects

Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron

Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants:a first step towards subpopulation-specific dosages

Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines

Suchergebnisse filtern